One of the primary challenges in initiating an immune response is coordinating cells distributed across different areas, often separated by physical barriers like endothelial cell layers. This communication relies on small molecules such as chemokines, which attract cells to specific locations, and cytokines, which assist in the differentiation of appropriate cells to generate a targeted immune response. Changes in cell surface adhesion molecules, triggered by innate immune receptor recognition, enable cells to exit the bloodstream and reach sites of injury to execute the immune response. The interaction between T cells and antigen-presenting cells is facilitated by antigen receptors and coreceptors, both of which must be simultaneously engaged for activation to occur. This dual recognition mechanism reduces the likelihood of T cells recognizing self-antigens on nonactivated antigen-presenting cells, thereby preventing autoimmune responses. Immune effector cells come in various forms, including neutrophils, macrophages, and innate lymphoid cells of the innate immune system, as well as helper T cells, cytotoxic T cells, and B cells of adaptive immunity. Innate immune cell activation occurs rapidly, while activation of adaptive immune cells requires cell division and differentiation, resulting in delayed effects. Despite the diversity of cell surface receptors and downstream effector, the immune system has evolved to reuse signaling transduction strategies. Similar signaling molecules are employed to translate diverse stimuli into functional cellular changes, with entire sections of signaling pathways recurring across different cell types. However, in each cell type, these pathways are linked to unique upstream receptors and downstream effectors.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related